Skip to content
Wholesale trade
KZActiveBIN 110740017775
Plans from 2 000 ₸ a month
1/17
High risk
Not present at its registered address
To risks

ТОО "АСТАНА МЕДИКАЛ ПРОДУКТ"

Director
Аргымбаева Асем Бакытжановна
Incorporated
28.07.2011
Address
Астана ул. ДОСТЫҚ, 5/1
РНН
620500010368

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

1/17
Not present at its registered addressHigh risk

Комитет государственных доходов · data as of 14.01.2026

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "АСТАНА МЕДИКАЛ ПРОДУКТ"
BIN
110740017775
Status
Active
Director
Аргымбаева Асем Бакытжановна
Registration date
28.07.2011
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Астана ул. ДОСТЫҚ, 5/1

In government contracts over 2 years

VAT payer
Yes, since 12.01.2026
КАТО
711210000
РНН
620500010368
КФС
Собственность иностранных физических лиц
КСЕ
Нефинансовые корпорации под иностранным контролем – ОПП
Company size
Малые предприятия
Employees
от 11 до 15 чел.
Procurement role
Поставщик

Activities

1

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
51M
2025
32.5M-47%
2024
62M+6%
2023
58.5M+80%
2022
32.5M+1695%
2021
1.8M
·51M
2026year to date
-47%32.5M
2025
+6%62M
2024
+80%58.5M
2023
+1695%32.5M
2022
·1.8M
2021
2026
Tax paid51,047,517 ₸
Penalty0 ₸
Fine21,625 ₸
VAT refund0 ₸
2025
Tax paid32,538,451 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid61,954,429 ₸
Penalty164,000 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid58,488,525 ₸
Penalty200 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid32,491,797 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid1,809,701 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

People & owners

Leadership

2
  • АА

    Аргымбаева Асем Бакытжановна

    Director

Former directors

  • СССУВОРОВ СТАНИСЛАВ ВАЛЕРЬЕВИЧ
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Networks & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "АСТАНА МЕДИКАЛ ПРОДУКТ" (BIN 110740017775) is an active legal entity in Астана, registered in 2011 (15 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 6, 2026: 98 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 515,618,609 ₸. Automated screening found 1 risk indicator for "АСТАНА МЕДИКАЛ ПРОДУКТ". Director on record — Аргымбаева Асем Бакытжановна. Data current as of November 6, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.